Last deal

$10.M

Amount

Series D

Stage

20.04.2016

Date

8

all rounds

$122.9M

Total amount

General

About Company
PowerVision develops implantable lenses that restore vision for people with presbyopia and cataracts.

Industry

Sector :

Subsector :

founded date

01.01.2002

Number of employees

Company Type

For Profit

Last funding type

Series D

IPO status

Private

Description

PowerVision's FluidVision accommodating intraocular lens is a breakthrough technology that uses a tiny amount of fluid inside the lens and natural eye muscles to adjust focus, restoring clear vision at all distances. The lens is designed to meet the clinical and lifestyle needs caused by presbyopia and cataracts, potentially giving patients freedom from glasses or any vision correction procedure. With over 20 million people with cataracts in the U.S. and more than 90 million with Presbyopia worldwide, PowerVision's innovative lens is set to revolutionize vision correction surgery for young, middle-aged, and elderly patients.
Contacts

Phone number

Social url